Mouse PD-L1/B7-H1 PicoKine ELISA Kit
To Order Contact us: [email protected]
 Recombinant Mouse PD-L1/B7-H1 Protein |
|||
| RP01149 | Abclonal | 10 μg | EUR 155 |
Recombinant Mouse PD-L1/B7-H1 Protein |
|||
| RP01158 | Abclonal | 20 μg | EUR 183 |
 ELISA kit for Human PD-L1/B7-H1 |
|||
| EK5678 | SAB | 96 tests | EUR 553 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human PD-L1/B7-H1 in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
 ELISA Kit) QuickDetect? PD-L1/B7-H1 (Human) ELISA Kit |
|||
| K4416-100 | Biovision | EUR 914 | |
 Polyclonal B7-H1 / PD-L1 / CD274 Antibody |
|||
| APR03374G | Leading Biology | 0.05ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human B7-H1 / PD-L1 / CD274 . This antibody is tested and proven to work in the following applications: |
|||
 Anti-PD-L1/B7-H1/CD274 Antibody |
|||
| A00109 | BosterBio | 100ug/vial | EUR 294 |
) PD-L1/B7-H1/CD274 (C-mFc) |
|||
| E21-M06 | EnoGene | 10ug | EUR 343 |
) PD-L1/B7-H1/CD274 (C-Flag) |
|||
| E21-M33 | EnoGene | 10ug | EUR 343 |
) PD-L1/B7-H1/CD274(Fc fusion) |
|||
| E21-M79 | EnoGene | 10ug | EUR 343 |
 Recombinant Human PD-L1/B7-H1 Protein |
|||
| RP00068 | Abclonal | 5 μg | EUR 136 |
Recombinant Human PD-L1/B7-H1 Protein |
|||
| RP00184 | Abclonal | 10 μg | EUR 149 |
 Human CellExp? PD-L1 /CD274 /B7-H1, mouse recombinant |
|||
| 7428-10 | Biovision | EUR 278 | |
Human CellExp? PD-L1 /CD274 /B7-H1, mouse recombinant |
|||
| 7428-50 | Biovision | EUR 718 | |
) Recombinant Mouse PD-L1/B7-H1/CD274 (C-6His) |
|||
| CJ88-10ug | Novoprotein | 10ug | EUR 100 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Mouse PD-L1/B7-H1/CD274 (C-6His) |
|||
| CJ88-1mg | Novoprotein | 1mg | EUR 1115 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Mouse PD-L1/B7-H1/CD274 (C-6His) |
|||
| CJ88-500ug | Novoprotein | 500ug | EUR 709 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Mouse PD-L1/B7-H1/CD274 (C-6His) |
|||
| CJ88-50ug | Novoprotein | 50ug | EUR 156 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
) Recombinant Mouse PD-L1/B7-H1/CD274 (C-Fc) |
|||
| CJ89-10ug | Novoprotein | 10ug | EUR 100 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Mouse PD-L1/B7-H1/CD274 (C-Fc) |
|||
| CJ89-1mg | Novoprotein | 1mg | EUR 1115 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Mouse PD-L1/B7-H1/CD274 (C-Fc) |
|||
| CJ89-500ug | Novoprotein | 500ug | EUR 709 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Mouse PD-L1/B7-H1/CD274 (C-Fc) |
|||
| CJ89-50ug | Novoprotein | 50ug | EUR 156 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
 Recombinant Rat PD-L1/B7-H1/CD274 Protein |
|||
| RP00800 | Abclonal | 10 μg | EUR 174 |
 Human CellExp? PD-L1 /CD274 /B7-H1, human recombinant |
|||
| 7429-10 | Biovision | EUR 224 | |
Human CellExp? PD-L1 /CD274 /B7-H1, human recombinant |
|||
| 7429-1000 | Biovision | Ask for price | |
Human CellExp? PD-L1 /CD274 /B7-H1, human recombinant |
|||
| 7429-250 | Biovision | EUR 2159 | |
Human CellExp? PD-L1 /CD274 /B7-H1, human recombinant |
|||
| 7429-50 | Biovision | EUR 604 | |
) Recombinant Human PD-L1/B7-H1/CD274 (C-mFc) |
|||
| CM06-10ug | Novoprotein | 10ug | EUR 115 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274 (C-mFc) |
|||
| CM06-1mg | Novoprotein | 1mg | EUR 1674 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274 (C-mFc) |
|||
| CM06-500ug | Novoprotein | 500ug | EUR 1186 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274 (C-mFc) |
|||
| CM06-50ug | Novoprotein | 50ug | EUR 202 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
) Recombinant Human PD-L1/B7-H1/CD274 (C-Flag) |
|||
| CM33-10ug | Novoprotein | 10ug | EUR 115 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB 150mM Nacl pH 7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274 (C-Flag) |
|||
| CM33-1mg | Novoprotein | 1mg | EUR 1674 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB 150mM Nacl pH 7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274 (C-Flag) |
|||
| CM33-500ug | Novoprotein | 500ug | EUR 1186 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB 150mM Nacl pH 7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274 (C-Flag) |
|||
| CM33-50ug | Novoprotein | 50ug | EUR 202 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB 150mM Nacl pH 7.4. |
|||
) Recombinant Human PD-L1/B7-H1/CD274(C-Fc) |
|||
| CM79-10ug | Novoprotein | 10ug | EUR 115 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274(C-Fc) |
|||
| CM79-1mg | Novoprotein | 1mg | EUR 1674 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274(C-Fc) |
|||
| CM79-500ug | Novoprotein | 500ug | EUR 1186 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274(C-Fc) |
|||
| CM79-50ug | Novoprotein | 50ug | EUR 202 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH7.4. |
|||
) Recombinant Human PD-L1/B7-H1/CD274 (C-6His) |
|||
| C315-1mg | Novoprotein | 1mg | EUR 1166 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, 5% Trehalose, pH 7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274 (C-6His) |
|||
| C315-500ug | Novoprotein | 500ug | EUR 831 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, 5% Trehalose, pH 7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274 (C-6His) |
|||
| C315-50ug | Novoprotein | 50ug | EUR 171 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, 5% Trehalose, pH 7.4. |
|||
Recombinant Human PD-L1/B7-H1/CD274 (C-6His) |
|||
| C315-10ug | Novoprotein | 10ug | EUR 90 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, 5% Trehalose, pH 7.4. |
|||
 (B7-H1), Rabbit Monoclonal Antibody) Anti-PD-L1 (CD274) (B7-H1), Rabbit Monoclonal Antibody |
|||
| A1824-50 | Biovision | Ask for price | |
) Mouse PD-L1/B7-H1 EZ-Set™ ELISA Kit (DIY Antibody Pairs) |
|||
| EZ1450 | BosterBio | 5 plates/kit | EUR 324 |
|
Description: NA |
|||
) Human Programmed Death Ligand 1 ELISA Kit (PD-L1/B7-H1/ CD274) |
|||
| RK04115 | Abclonal | 96 Tests | EUR 606 |
) PD-L1 / PDCD1LG1 / CD274 / B7-H1; Clone PDL1/2746 (Concentrate) |
|||
| RA0501-C.1 | ScyTek Laboratories | 0.1 ml | EUR 125 |
PD-L1 / PDCD1LG1 / CD274 / B7-H1; Clone PDL1/2746 (Concentrate) |
|||
| RA0501-C.5 | ScyTek Laboratories | 0.5 ml | EUR 300 |
PD-L1 / PDCD1LG1 / CD274 / B7-H1; Clone PDL1/2746 (Concentrate) |
|||
| RA0501-C1 | ScyTek Laboratories | 1 ml | EUR 500 |
 Human PD-L2/B7-DC PicoKine ELISA Kit |
|||
| EK1447 | BosterBio | 96 wells | EUR 425 |
|
Description: For Quantitative Detection of human PD-L2 in cell culture supernates, serum and plasma (heparin, EDTA). |
|||
 Monoclonal antibody, clone 10F.9G2) Rat Anti-Mouse PD-L1 (B7-H1) Monoclonal antibody, clone 10F.9G2 |
|||
| CABT-L4404-1mg | Creative Diagnostics | 1 mg | EUR 897 |
Rat Anti-Mouse PD-L1 (B7-H1) Monoclonal antibody, clone 10F.9G2 |
|||
| CABT-L4404-5mg | Creative Diagnostics | 5 mg | EUR 2405 |
 Monoclonal antibody, clone 29E.2A3) Mouse Anti-Human PD-L1 (B7-H1) Monoclonal antibody, clone 29E.2A3 |
|||
| CABT-L4518-1mg | Creative Diagnostics | 1 mg | EUR 897 |
Mouse Anti-Human PD-L1 (B7-H1) Monoclonal antibody, clone 29E.2A3 |
|||
| CABT-L4518-5mg | Creative Diagnostics | 5 mg | EUR 2405 |
 (B7-H1) Rabbit Monoclonal Antibody, Clone#RM320) Anti-PD-L1 (CD274) (B7-H1) Rabbit Monoclonal Antibody, Clone#RM320 |
|||
| M00109-1 | BosterBio | 100uL | EUR 427 |
|
Description: Anti-PD-L1 (CD274) (B7-H1) Rabbit Monoclonal Antibody, Clone#RM320 tested in WB, IHC, reactive to Human |
|||
 (PDL1/2746) Antibody) PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNUM2746-50 | Biotium | 50uL | EUR 405 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), 1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNCR2746-250 | Biotium | 250uL | EUR 394 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), RPE conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNUB2746-100 | Biotium | 100uL | EUR 264 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Concentration: 0.2mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNUB2746-500 | Biotium | 500uL | EUR 513 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Concentration: 0.2mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC552746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF555 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC552746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF555 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC432746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF543 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC432746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF543 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC472746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF647 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC472746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF647 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC042746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405S conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC042746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405S conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC052746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405M conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC052746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF405M conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC402746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF640R conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC402746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF640R conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC702746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF770 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC702746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF770 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC802746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC802746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNCH2746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNCH2746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNCP2746-250 | Biotium | 250uL | EUR 394 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), PerCP conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC942746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC942746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNCA2746-250 | Biotium | 250uL | EUR 394 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), APC conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNCB2746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Biotin conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNCB2746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Biotin conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC882746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF488A conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC882746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF488A conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC682746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC682746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF568 conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNCAP2746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNCAP2746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC812746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680R conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC812746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF680R conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC612746-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF660R conjugate, Concentration: 0.1mg/mL |
|||
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746) Antibody |
|||
| BNC612746-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF660R conjugate, Concentration: 0.1mg/mL |
|||
) Programmed Cell Death 1 Ligand 1/PD-L1/B7-H1/CD274 (C-Fc-Avi) |
|||
| E21-CU02 | EnoGene | 10ug | EUR 343 |
 Human PD-L1 Elisa Kit |
|||
| QY-E05642 | Qayee Biotechnology | 96T | EUR 361 |
 Mouse PD-L1 Antibody |
|||
| 32903-05111 | AssayPro | 150 ug | EUR 261 |